Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

William A Robinson

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Phone303/724-3870

    Collapse Research 
    Collapse research activities and funding
    T32CA009331     (KANE, MADELEINE A)Sep 1, 1981 - Aug 31, 1991
    NIH
    POSTGRADUATE TRAINING IN CANCER RESEARCH
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Turner JA, Paton EL, Van Gulick R, Stefanoni D, Cendali F, Reisz J, Tobin RP, McCarter M, D'Alessandro A, Torres RM, Robinson WA, Couts KL, Schlaepfer IR. BRAF Modulates Lipid Use and Accumulation. Cancers (Basel). 2022 Apr 23; 14(9). PMID: 35565240.
      View in: PubMed
    2. Vorwald VM, Davis DM, Van Gulick RJ, Torphy RJ, Borgers JS, Klarquist J, Couts KL, Amato CM, Cogswell DT, Fujita M, Castleman MJ, Davis T, Lozupone C, Medina TM, Robinson WA, Gapin L, McCarter MD, Tobin RP. Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients. Clin Transl Immunology. 2022; 11(1):e1367. PMID: 35028137.
      View in: PubMed
    3. Mukherjee N, Dart CR, Amato CM, Honig-Frand A, Lambert JR, Lambert KA, Robinson WA, Tobin RP, McCarter MD, Couts KL, Fujita M, Norris DA, Shellman YG. Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics. J Invest Dermatol. 2022 Jul; 142(7):1912-1922.e7. PMID: 34942200.
      View in: PubMed
    4. Torphy RJ, Friedman C, Ho F, Leonard LD, Thieu D, Lewis KD, Medina TM, Robinson WA, Gonzalez RC, Stewart CL, Kounalakis N, McCarter MD, Gleisner A. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection. Ann Surg Oncol. 2022 Feb; 29(2):806-815. PMID: 34537899.
      View in: PubMed
    5. Dart CR, Mukherjee N, Amato CM, Goulding A, MacBeth M, Van Gulick R, Couts KL, Lambert JR, Norris DA, Robinson WA, Shellman YG. A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel). 2021 Jul 30; 14(8). PMID: 34451846.
      View in: PubMed
    6. Lee H, Li T, Wisell J, Schowinsky J, Robinson WA. Avapritinib for Cutaneous Mastocytosis. Acta Derm Venereol. 2021 Jan 05; 101(1):adv00362. PMID: 33241424.
      View in: PubMed
    7. Holman BN, Van Gulick RJ, Amato CM, MacBeth ML, Davies KD, Aisner DL, Robinson WA, Couts KL. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas. Melanoma Res. 2020 12; 30(6):562-573. PMID: 33156595.
      View in: PubMed
    8. Newell F, Wilmott JS, Johansson PA, Nones K, Addala V, Mukhopadhyay P, Broit N, Amato CM, Van Gulick R, Kazakoff SH, Patch AM, Koufariotis LT, Lakis V, Leonard C, Wood S, Holmes O, Xu Q, Lewis K, Medina T, Gonzalez R, Saw RPM, Spillane AJ, Stretch JR, Rawson RV, Ferguson PM, Dodds TJ, Thompson JF, Long GV, Levesque MP, Robinson WA, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Hayward NK. Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun. 2020 10 16; 11(1):5259. PMID: 33067454.
      View in: PubMed
    9. Goldstein NB, Steel A, Barbulescu CC, Koster MI, Wright MJ, Jones KL, Gao B, Ward B, Woessner B, Trottier Z, Pakieser J, Hu J, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. J Invest Dermatol. 2021 03; 141(3):638-647.e13. PMID: 32800877.
      View in: PubMed
    10. Amato CM, Hintzsche JD, Wells K, Applegate A, Gorden NT, Vorwald VM, Tobin RP, Nassar K, Shellman YG, Kim J, Medina TM, Rioth M, Lewis KD, McCarter MD, Gonzalez R, Tan AC, Robinson WA. Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers (Basel). 2020 Jul 17; 12(7). PMID: 32708981.
      View in: PubMed
    11. Carlson BC, Hines JT, Robinson WA, Sebastian AS, Greenwood-Quaintance KE, Patel R, Huddleston PM. Implant Sonication versus Tissue Culture for the Diagnosis of Spinal Implant Infection. Spine (Phila Pa 1976). 2020 May 01; 45(9):E525-E532. PMID: 32282655.
      View in: PubMed
    12. Tobin RP, Jordan KR, Kapoor P, Spongberg E, Davis D, Vorwald VM, Couts KL, Gao D, Smith DE, Borgers JSW, Robinson S, Amato C, Gonzalez R, Lewis KD, Robinson WA, Borges VF, McCarter MD. IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients. Front Oncol. 2019; 9:1223. PMID: 31781510.
      View in: PubMed
    13. Mackin AG, Pecen PE, Dinsmore AL, Patnaik JL, Gonzalez R, Robinson WA, Palestine AG. Inflammatory side effects of BRAF and MEK inhibitors. Melanoma Res. 2019 10; 29(5):522-526. PMID: 30870269.
      View in: PubMed
    14. Osborne DG, Domenico J, Luo Y, Reid AL, Amato C, Zhai Z, Gao D, Ziman M, Dinarello CA, Robinson WA, Fujita M. Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome. Mol Carcinog. 2019 09; 58(9):1670-1679. PMID: 31099111.
      View in: PubMed
    15. Halpern AL, Torphy RJ, McCarter MD, Sciotto CG, Glode LM, Robinson WA. A familial germline mutation in KIT associated with achalasia, mastocytosis and gastrointestinal stromal tumors shows response to kinase inhibitors. Cancer Genet. 2019 04; 233-234:1-6. PMID: 31109590.
      View in: PubMed
    16. Robinson WA, Hevesi M, Carlson BC, Schulte S, Petfield JL, Freedman BA. Spinal Fusions in Active Military Personnel: Who Gets a Lumbar Spinal Fusion in the Military and What Impact Does It Have on Service Member Retention? Mil Med. 2019 01 01; 184(1-2):e156-e161. PMID: 30690620.
      View in: PubMed
    17. Wyles CC, Robinson WA, Maradit-Kremers H, Houdek MT, Trousdale RT, Mabry TM. Cost and Patient Outcomes Associated With Bilateral Total Knee Arthroplasty Performed by 2-Surgeon Teams vs a Single Surgeon. J Arthroplasty. 2019 04; 34(4):671-675. PMID: 30661905.
      View in: PubMed
    18. Ravindran Menon D, Luo Y, Arcaroli JJ, Liu S, KrishnanKutty LN, Osborne DG, Li Y, Samson JM, Bagby S, Tan AC, Robinson WA, Messersmith WA, Fujita M. CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma. Cancer Res. 2018 12 01; 78(23):6561-6574. PMID: 30297536.
      View in: PubMed
    19. Mukherjee N, Strosnider A, Vagher B, Lambert KA, Slaven S, Robinson WA, Amato CM, Couts KL, Bemis JGT, Turner JA, Norris DA, Shellman YG. BH3 mimetics induce apoptosis independent of DRP-1 in melanoma. Cell Death Dis. 2018 09 05; 9(9):907. PMID: 30185782.
      View in: PubMed
    20. Tobin RP, Jordan KR, Robinson WA, Davis D, Borges VF, Gonzalez R, Lewis KD, McCarter MD. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. Int Immunopharmacol. 2018 Oct; 63:282-291. PMID: 30121453.
      View in: PubMed
    21. Carlson BC, Robinson WA, Wanderman NR, Nassr AN, Huddleston PM, Yaszemski MJ, Currier BL, Jeray KJ, Kirk KL, Bunta AD, Murphy S, Patel B, Watkins CM, Sietsema DL, Edwards BJ, Tosi LL, Anderson PA, Freedman BA. The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients. Osteoporos Int. 2018 Sep; 29(9):2101-2109. PMID: 29858634.
      View in: PubMed
    22. Lee H, King G, Garg K, Pan Z, Tobin J, Robinson WA. Successful treatment of disseminated Rosai-Dorfman disease with siltuximab. Haematologica. 2018 07; 103(7):e325-e328. PMID: 29599203.
      View in: PubMed
    23. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29697364.
      View in: PubMed
    24. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29269140.
      View in: PubMed
    25. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30254212.
      View in: PubMed
    26. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 27193292.
      View in: PubMed
    27. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 27702820.
      View in: PubMed
    28. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 27086916.
      View in: PubMed
    29. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28070503.
      View in: PubMed
    30. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30482852.
      View in: PubMed
    31. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 31602665.
      View in: PubMed
    32. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 32324159.
      View in: PubMed
    33. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 32513939.
      View in: PubMed
    34. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30657954.
      View in: PubMed
    35. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 32764384.
      View in: PubMed
    36. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 31770343.
      View in: PubMed
    37. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 9918411.
      View in: PubMed
    38. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7015352.
      View in: PubMed
    39. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18304967.
      View in: PubMed
    40. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 6401816.
      View in: PubMed
    41. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 8526190.
      View in: PubMed
    42. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 6364801.
      View in: PubMed
    43. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 6971759.
      View in: PubMed
    44. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7031871.
      View in: PubMed
    45. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 3531952.
      View in: PubMed
    46. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 5083423.
      View in: PubMed
    47. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 22189301.
      View in: PubMed
    48. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 8476254.
      View in: PubMed
    49. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7763129.
      View in: PubMed
    50. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 21698244.
      View in: PubMed
    51. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17540308.
      View in: PubMed
    52. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 10721718.
      View in: PubMed
    53. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1768370.
      View in: PubMed
    54. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1823632.
      View in: PubMed
    55. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17381803.
      View in: PubMed
    56. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1926358.
      View in: PubMed
    57. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18190445.
      View in: PubMed
    58. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1486560.
      View in: PubMed
    59. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15255167.
      View in: PubMed
    60. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 8412177.
      View in: PubMed
    61. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7864027.
      View in: PubMed
    62. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 20849464.
      View in: PubMed
    63. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23664431.
      View in: PubMed
    64. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 25822579.
      View in: PubMed
    65. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 26203640.
      View in: PubMed
    66. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7013856.
      View in: PubMed
    67. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 844516.
      View in: PubMed
    68. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7014235.
      View in: PubMed
    69. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 4514501.
      View in: PubMed
    70. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 36751.
      View in: PubMed
    71. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 400704.
      View in: PubMed
    72. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 11455554.
      View in: PubMed
    73. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 21349.
      View in: PubMed
    74. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 35172482.
      View in: PubMed
    75. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 34873347.
      View in: PubMed
    76. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 34348236.
      View in: PubMed
    77. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 7804974.
      View in: PubMed
    78. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 5285545.
      View in: PubMed
    79. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 5540628.
      View in: PubMed
    80. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 2189999.
      View in: PubMed
    81. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 6509348.
      View in: PubMed
    82. Couts KL, Bemis J, Turner JA, Bagby SM, Murphy D, Christiansen J, Hintzsche JD, Le A, Pitts TM, Wells K, Applegate A, Amato C, Multani P, Chow-Maneval E, Tentler JJ, Shellman YG, Rioth MJ, Tan AC, Gonzalez R, Medina T, Doebele RC, Robinson WA. ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms. Mol Cancer Ther. 2018 01; 17(1):222-231. PMID: 29054983.
      View in: PubMed
    83. Goldstein NB, Koster MI, Jones KL, Gao B, Hoaglin LG, Robinson SE, Wright MJ, Birlea SI, Luman A, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the ß-Catenin Pathway in the Hair Follicle Bulge Stem Cells. J Invest Dermatol. 2018 03; 138(3):657-668. PMID: 29054607.
      View in: PubMed
    84. Korch C, Hall EM, Dirks WG, Ewing M, Faries M, Varella-Garcia M, Robinson S, Storts D, Turner JA, Wang Y, Burnett EC, Healy L, Kniss D, Neve RM, Nims RW, Reid YA, Robinson WA, Capes-Davis A. Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. Int J Cancer. 2018 02 01; 142(3):561-572. PMID: 28940260.
      View in: PubMed
    85. Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma. Melanoma Res. 2017 06; 27(3):189-199. PMID: 28296713.
      View in: PubMed
    86. Mukherjee N, Almeida A, Partyka KA, Lu Y, Schwan JV, Lambert K, Rogers M, Robinson WA, Robinson SE, Applegate AJ, Amato CM, Luo Y, Fujita M, Norris DA, Shellman YG. Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments. Oncotarget. 2016 Dec 20; 7(51):84594-84607. PMID: 27829238.
      View in: PubMed
    87. Hintzsche J, Kim J, Yadav V, Amato C, Robinson SE, Seelenfreund E, Shellman Y, Wisell J, Applegate A, McCarter M, Box N, Tentler J, De S, Robinson WA, Tan AC. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples. J Am Med Inform Assoc. 2016 07; 23(4):721-30. PMID: 27026619.
      View in: PubMed
    88. Seelenfreund E, Robinson WA, Amato CM, Tan AC, Kim J, Robinson SE. Long term storage of dry versus frozen RNA for next generation molecular studies. PLoS One. 2014; 9(11):e111827. PMID: 25380187.
      View in: PubMed
    89. Mukherjee N, Reuland SN, Lu Y, Luo Y, Lambert K, Fujita M, Robinson WA, Robinson SE, Norris DA, Shellman YG. Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells. J Invest Dermatol. 2015 Mar; 135(3):842-850. PMID: 25350317.
      View in: PubMed
    90. Ross E, Robinson SE, Amato C, McMillan C, Westcott J, Wolf T, Robinson WA. Therapeutic monoclonal antibodies in human breast milk: a case study. Melanoma Res. 2014 Apr; 24(2):177-80. PMID: 24476799.
      View in: PubMed
    91. Redzic JS, Kendrick AA, Bahmed K, Dahl KD, Pearson CG, Robinson WA, Robinson SE, Graner MW, Eisenmesser EZ. Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-ß1 and EMMPRIN. PLoS One. 2013; 8(8):e71225. PMID: 23936495.
      View in: PubMed
    92. Jones EL, Jones TS, Pearlman NW, Gao D, Stovall R, Gajdos C, Kounalakis N, Gonzalez R, Lewis KD, Robinson WA, McCarter MD. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013 May; 148(5):456-61. PMID: 23325294.
      View in: PubMed
    93. Keysar SB, Astling DP, Anderson RT, Vogler BW, Bowles DW, Morton JJ, Paylor JJ, Glogowska MJ, Le PN, Eagles-Soukup JR, Kako SL, Takimoto SM, Sehrt DB, Umpierrez A, Pittman MA, Macfadden SM, Helber RM, Peterson S, Hausman DF, Said S, Leem TH, Goddard JA, Arcaroli JJ, Messersmith WA, Robinson WA, Hirsch FR, Varella-Garcia M, Raben D, Wang XJ, Song JI, Tan AC, Jimeno A. A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol. 2013 Aug; 7(4):776-90. PMID: 23607916.
      View in: PubMed
    94. Deng H, Liu J, Deng Y, Han G, Shellman YG, Robinson SE, Tentler JJ, Robinson WA, Norris DA, Wang XJ, Zhang Q. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1. J Invest Dermatol. 2013 May; 133(5):1294-301. PMID: 23303449.
      View in: PubMed
    95. Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD, Wang J, Gonzalez R, Thompson DC, Norris DA, Roop DR, Vasiliou V, Fujita M. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012 Oct; 30(10):2100-13. PMID: 22887839.
      View in: PubMed
    96. Ellis LZ, Prado R, High W, Robinson WA, Mellette JR. Sweat gland carcinoma versus metastatic breast carcinoma: a continued struggle among clinicians and dermatopathologists. J Am Acad Dermatol. 2012 Oct; 67(4):e156-7. PMID: 22980278.
      View in: PubMed
    97. Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R, Norris DA, Roop DR, Spritz RA, Ahn NG, Fujita M. Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol. 2012 Oct; 132(10):2440-2450. PMID: 22622430.
      View in: PubMed
    98. Robinson WA, McMillan C, Kendall A, Pearlman N. Desmoid tumors in pregnant and postpartum women. Cancers (Basel). 2012 Feb 21; 4(1):184-92. PMID: 24213235.
      View in: PubMed
    99. Seelenfreund E, Robinson SE, Amato CM, Bemis LT, Robinson WA. Recovery of MicroRNA from Stored Human Peripheral Blood Samples. Biopreserv Biobank. 2011 Mar; 9(1):29-33. PMID: 24850203.
      View in: PubMed
    100. Juhl AL, Byers TE, Robinson WA, Morelli JG, Crane LA. The anatomic distribution of melanoma and relationships with childhood nevus distribution in Colorado. Melanoma Res. 2009 Aug; 19(4):252-9. PMID: 19543126.
      View in: PubMed
    101. Amaria RN, Corboy JR, Finlayson CA, Robinson WA, Borges VF. Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review. Clin Breast Cancer. 2008 Oct; 8(5):449-52. PMID: 18952560.
      View in: PubMed
    102. Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD. Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res. 2009 Jun 01; 154(1):13-20. PMID: 19062042.
      View in: PubMed
    103. Lyle PL, Amato CM, Fitzpatrick JE, Robinson WA. Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol. 2008 Jun; 32(6):858-66. PMID: 18408594.
      View in: PubMed
    104. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG, Robinson WA. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood. 2008 Aug 01; 112(3):822-9. PMID: 18483394.
      View in: PubMed
    105. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, Robinson WA. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res. 2008 Mar 01; 68(5):1362-8. PMID: 18316599.
      View in: PubMed
    106. Lewis KD, Robinson WA, Millward MJ, Powell A, Price TJ, Thomson DB, Walpole ET, Haydon AM, Creese BR, Roberts KL, Zalcberg JR, Gonzalez R. A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs. 2008 Feb; 26(1):89-94. PMID: 17891338.
      View in: PubMed
    107. Escobar GA, Robinson WA, Nydam TL, Heiple DC, Weiss GJ, Buckley L, Gonzalez R, McCarter MD. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report. BMC Cancer. 2007 Jan 17; 7:13. PMID: 17229322.
      View in: PubMed
    108. High WA, Robinson WA. Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol. 2007; 23:61-79. PMID: 18159896.
      View in: PubMed
    109. Pearlman NW, McCarter MD, Frank M, Hurtubis C, Merkow RP, Franklin WA, Gonzalez R, Lewis K, Roaten JB, Robinson WA. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006 Dec; 192(6):878-81. PMID: 17161112.
      View in: PubMed
    110. Ravdel L, Robinson WA, Lewis K, Gonzalez R. Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol. 2006 Aug 01; 94(2):101-4. PMID: 16847918.
      View in: PubMed
    111. Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol. 2006 Jul 01; 24(19):3157-63. PMID: 16809738.
      View in: PubMed
    112. Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS. Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res. 2006 Feb 15; 12(4):1137-43. PMID: 16489066.
      View in: PubMed
    113. Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94. PMID: 16379038.
      View in: PubMed
    114. Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial. J Clin Oncol. 2005 Nov 01; 23(31):8057-64. PMID: 16258104.
      View in: PubMed
    115. Tayal S, Classen E, Bemis L, Robinson WA. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis. Anticancer Res. 2005 May-Jun; 25(3B):2215-20. PMID: 16158966.
      View in: PubMed
    116. Singh M, Parnes MB, Spoelstra N, Bleile MJ, Robinson WA. p16 expression in sentinel nodes with metastatic breast carcinoma: evaluation of its role in developing triaging strategies for axillary node dissection and a marker of poor prognosis. Hum Pathol. 2004 Dec; 35(12):1524-30. PMID: 15619212.
      View in: PubMed
    117. Qi L, Robinson WA, Brady BM, Glode LM. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors. Anticancer Res. 2003 Sep-Oct; 23(5A):3917-22. PMID: 14666697.
      View in: PubMed
    118. Robinson WA, Miller TL, Harrold EA, Bemis LT, Brady BM, Nelson RP. The effect of flavopiridol on the growth of p16+ and p16- melanoma cell lines. Melanoma Res. 2003 Jun; 13(3):231-8. PMID: 12777976.
      View in: PubMed
    119. Gibbs P, Brady BM, Robinson WA. The genes and genetics of malignant melanoma. J Cutan Med Surg. 2002 May-Jun; 6(3):229-35. PMID: 11951125.
      View in: PubMed
    120. Gibbs P, Brady BM, Gonzalez R, Robinson WA. Nevi and melanoma: lessons from Turner's syndrome. Dermatology. 2001; 202(1):1-3. PMID: 11244219.
      View in: PubMed
    121. Gibbs P, Cebon JS, Calafiore P, Robinson WA. Cardiac metastases from malignant melanoma. Cancer. 1999 Jan 01; 85(1):78-84. PMID: 9921977.
      View in: PubMed
    122. Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Bartolucci AA, Rosen L. Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg. 1998 Jul; 187(1):69-77; discussion 77-9. PMID: 9660028.
      View in: PubMed
    123. Gibbs P, Chen Q, Robinson WA. Effects of oncostatin M and tamoxifen on human melanoma cells. Melanoma Res. 1998 Jun; 8(3):221-6. PMID: 9664143.
      View in: PubMed
    124. Wallack MK, Sivanandham M, Ditaranto K, Shaw P, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty L, Richards JM, Rosen L, Bartolucci AA. Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: second interim analysis of data from a phase III, multi-institutional trial. Ann Surg. 1997 Aug; 226(2):198-206. PMID: 9296514.
      View in: PubMed
    125. Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma. 1997 Jan; 42(1):104-7. PMID: 9003266.
      View in: PubMed
    126. Robinson WA, Elefanty AG, Hersey P. Expression of the tumour suppressor genes p15 and p16 in malignant melanoma. Melanoma Res. 1996 Aug; 6(4):285-9. PMID: 8873047.
      View in: PubMed
    127. Dreiling L, Hoffman S, Robinson WA. Melanoma: epidemiology, pathogenesis, and new modes of treatment. Adv Intern Med. 1996; 41:553-604. PMID: 8903599.
      View in: PubMed
    128. Pearlman NW, Robinson WA, Dreiling LK, McIntyre RC, Gonzales R. Modified ilioinguinal node dissection for metastatic melanoma. Am J Surg. 1995 Dec; 170(6):647-9; discussion 649-50. PMID: 7492019.
      View in: PubMed
    129. Schofield JR, Robinson WA, Murphy JR, Rovira DK. Low doses of interferon-alpha are as effective as higher doses in inducing remissions and prolonging survival in chronic myeloid leukemia. Ann Intern Med. 1994 Nov 15; 121(10):736-44. PMID: 7944050.
      View in: PubMed
    130. McElhinney DB, Hoffman SJ, Robinson WA, Ferguson J. Effect of melatonin on human skin color. J Invest Dermatol. 1994 Feb; 102(2):258-9. PMID: 8106756.
      View in: PubMed
    131. Kane MA, Johnson A, Nash AE, Boose D, Mathai G, Balmer C, Yohn JJ, Robinson WA. Serum melatonin levels in melanoma patients after repeated oral administration. Melanoma Res. 1994 Feb; 4(1):59-65. PMID: 8032220.
      View in: PubMed
    132. Morse HG, Moore GE, Ortiz LM, Gonzalez R, Robinson WA. Malignant melanoma: from subcutaneous nodule to brain metastasis. Cancer Genet Cytogenet. 1994 Jan; 72(1):16-23. PMID: 8111733.
      View in: PubMed
    133. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer. 1994; 22(3):233-45. PMID: 7877893.
      View in: PubMed
    134. Pearlman NW, Takach TJ, Robinson WA, Ferguson J, Cohen AL. A case-control study of late recurrence of malignant melanoma. Am J Surg. 1992 Nov; 164(5):458-60; discussion 460-1. PMID: 1443369.
      View in: PubMed
    135. Arora R, Robinson WA. Breast metastases from malignant melanoma. J Surg Oncol. 1992 May; 50(1):27-9. PMID: 1573892.
      View in: PubMed
    136. Sanchez A, Robinson WA, Cohn A, Gonzalez R, Adlakha A. Low-dose alpha-interferon treatment of chronic myeloid leukemia. Am J Hematol. 1992 Jan; 39(1):61-2. PMID: 1536141.
      View in: PubMed
    137. Feun LG, Gonzalez R, Savaraj N, Hanlon J, Collier M, Robinson WA, Clendeninn NJ. Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration. J Clin Oncol. 1991 Mar; 9(3):464-7. PMID: 1999717.
      View in: PubMed
    138. Mughal TI, Thomas MR, Robinson WA. Role of recombinant alpha-interferon in the treatment of advanced cutaneous malignant melanoma. Oncology. 1991; 48(5):365-8. PMID: 1745482.
      View in: PubMed
    139. Brega K, Robinson WA, Winston K, Wittenberg W. Surgical treatment of brain metastases in malignant melanoma. Cancer. 1990 Nov 15; 66(10):2105-10. PMID: 2224765.
      View in: PubMed
    140. Herr R, Ferguson J, Myers N, Rovira D, Robinson WA. Cigarette smoking, blast crisis, and survival in chronic myeloid leukemia. Am J Hematol. 1990 May; 34(1):1-4. PMID: 2327399.
      View in: PubMed
    141. Robinson WA. Malignant melanoma as a model for cancer education and prevention. 1989 Harvey lecture American Association for Cancer Education. J Cancer Educ. 1990; 5(2):85-9. PMID: 2206936.
      View in: PubMed
    142. Steele MT, Sainsbury CR, Robinson WA, Salomone JA, Elenbaas RM. Prophylactic penicillin for intraoral wounds. Ann Emerg Med. 1989 Aug; 18(8):847-52. PMID: 2502938.
      View in: PubMed
    143. Frontiera M, Murray JL, Lamki L, Thomas J, Satterlee W, Schmelter R, Rosenblum MG, Khazaeli MB, Unger MW, Robinson WA, et al. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma. Clin Nucl Med. 1989 May; 14(5):357-66. PMID: 2656042.
      View in: PubMed
    144. Gordon GS, Ambruso DR, Robinson WA, Githens JH. Intranasal administration of deferoxamine to iron overloaded patients. Am J Med Sci. 1989 May; 297(5):280-4. PMID: 2640419.
      View in: PubMed
    145. Rifkin RM, Thomas MR, Mughal TI, Kaur JS, Krebs LU, Robinson WA. Malignant melanoma--profile of an epidemic. West J Med. 1988 Jul; 149(1):43-6. PMID: 3407161.
      View in: PubMed
    146. Hoffman SJ, Robinson WA. Use of differentiation-inducing agents in the myelodysplastic syndrome and acute non-lymphocytic leukemia. Am J Hematol. 1988 Jun; 28(2):124-7. PMID: 3293438.
      View in: PubMed
    147. Stork LC, Peterson VM, Rundus CH, Robinson WA. Interleukin-1 enhances murine granulopoiesis in vivo. Exp Hematol. 1988 Feb; 16(2):163-7. PMID: 3257444.
      View in: PubMed
    148. Mughal TI, Robinson WA, Thomas MR, Spiegel R. Role of recombinant interferon alpha 2 and cimetidine in patients with advanced malignant melanoma. J Cancer Res Clin Oncol. 1988; 114(1):108-9. PMID: 3350837.
      View in: PubMed
    149. Gordon GS, Hathaway WE, Robinson WA. Lack of effectiveness of intranasal administration of human factor VIII. Ann Intern Med. 1987 Nov; 107(5):788. PMID: 3116903.
      View in: PubMed
    150. Zartman GM, Thomas MR, Robinson WA. Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol. 1987 Jul; 35(3):163-4. PMID: 3599990.
      View in: PubMed
    151. Iyengar VG, Peterson VM, Rundus C, Robinson WA. Postburn serum inhibits in vitro production of colony-stimulating factor by mononuclear peripheral blood cells. Int J Cell Cloning. 1986 Nov; 4(6):472-82. PMID: 3023500.
      View in: PubMed
    152. Robinson WA, Mughal TI, Thomas MR, Johnson M, Spiegel RJ. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. Immunobiology. 1986 Sep; 172(3-5):275-82. PMID: 3804370.
      View in: PubMed
    153. Schmelter RF, Friefeld GD, Thomas J, Robinson WA. Diagnosis of malignant melanoma with radiolabeled monoclonal antibodies: current status. Drug Intell Clin Pharm. 1986 Feb; 20(2):125-33. PMID: 3485041.
      View in: PubMed
    154. Thomas MR, Robinson WA. Oncologic emergencies in primary care. Five malignancy-associated conditions to watch for. Postgrad Med. 1985 Sep 15; 78(4):41-9. PMID: 4034454.
      View in: PubMed
    155. Elenbaas RM, Frost GL, Robinson WA, Collier RE, McNabney WK, Ryan JL, Singsank MJ. Subcutaneous epinephrine vs. nebulized metaproterenol in acute asthma. Drug Intell Clin Pharm. 1985 Jul-Aug; 19(7-8):567-71. PMID: 4028963.
      View in: PubMed
    156. Peterson VM, Robinson WA, Wallner SF, Rundus C, Hansbrough JF. Granulocyte stem cells are decreased in humans with fatal burns. J Trauma. 1985 May; 25(5):413-8. PMID: 3999161.
      View in: PubMed
    157. Mughal TI, Robinson WA, Padmos MA. Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol. 1985 Mar; 11(1):41-5. PMID: 3987911.
      View in: PubMed
    158. Takasaki Y, Robinson WA, Tan EM. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia. J Natl Cancer Inst. 1984 Sep; 73(3):655-61. PMID: 6147434.
      View in: PubMed
    159. Mughal TI, Robinson WA, Thomas MR, Glode LM. Malignant melanoma and BCNU. Clin Oncol. 1984 Jun; 10(2):185. PMID: 6734009.
      View in: PubMed
    160. Thomas MR, Robinson WA, Mughal TI, Glode LM. Tumor lysis syndrome following VP-16-213 in chronic myeloid leukemia in blast crisis. Am J Hematol. 1984 Feb; 16(2):185-8. PMID: 6582781.
      View in: PubMed
    161. Wettlaufer JN, Feiner AS, Robinson WA. Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors. Cancer. 1984 Jan 15; 53(2):203-9. PMID: 6197154.
      View in: PubMed
    162. Chitambar CR, Robinson WA, Glode LM. Familial leukemia and aplastic anemia associated with monosomy 7. Am J Med. 1983 Nov; 75(5):756-62. PMID: 6638045.
      View in: PubMed
    163. Mughal TI, Phillips RH, Robinson WA. Bladder carcinoma presenting as a solitary bony metastasis. J Urol. 1983 Nov; 130(5):973. PMID: 6632111.
      View in: PubMed
    164. Thomas MR, Robinson WA, Boyle DJ, Day JF, Entringer MA, Steigerwald JF. Longterm effects of cyclophosphamide on granulocyte colony formation in patients with rheumatoid arthritis. J Rheumatol. 1983 Oct; 10(5):778-83. PMID: 6644700.
      View in: PubMed
    165. Dantas ME, Brown JP, Thomas MR, Robinson WA, Glode LM. Detection of melanoma cells in bone marrow using monoclonal antibodies. A comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Cancer. 1983 Sep 15; 52(6):949-53. PMID: 6349783.
      View in: PubMed
    166. Robinson WA, Entringer MA, Mahmoud LA, Drebing CJ. Schistosomal stimulation of eosinophil production by human bone marrow in vitro. Am J Hematol. 1983 May; 14(3):207-13. PMID: 6601907.
      View in: PubMed
    167. Thomas PJ, Kaur JS, Aitcheson CT, Robinson WA, Tan EM. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res. 1983 Mar; 43(3):1372-80. PMID: 6337706.
      View in: PubMed
    168. Thomas MR, Robinson WA, Glode LM, Dantas ME, Koeppler H, Morton N, Sutherland J. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. Am J Clin Oncol. 1982 Dec; 5(6):611-22. PMID: 6762087.
      View in: PubMed
    169. Bolin RW, Robinson WA, Sutherland J, Hamman RF. Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. Cancer. 1982 Nov 01; 50(9):1683-6. PMID: 6956430.
      View in: PubMed
    170. Glode LM, Robinson WA, Hartmann DW, Klein JJ, Thomas MR, Morton N. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res. 1982 Oct; 42(10):4270-5. PMID: 6286106.
      View in: PubMed
    171. Wallner SF, Vautrin RM, Buerk C, Robinson WA, Peterson VM. The anemia of thermal injury: studies of erythropoiesis in vitro. J Trauma. 1982 Sep; 22(9):774-80. PMID: 7120531.
      View in: PubMed
    172. Mahmoud LA, Robinson WA, Entringer MA. Urinary granulocyte colony-stimulating factor in bilharziasis. Am J Trop Med Hyg. 1982 May; 31(3 Pt 1):518-21. PMID: 6979263.
      View in: PubMed
    173. Triebel F, Robinson WA, Hayward AR, Goube de Laforest PG. Existence of a pool of T-lymphocyte colony-forming cells (T-CFC) in human bone marrow and their place in the differentiation of the T-lymphocyte lineage. Blood. 1981 Nov; 58(5):911-5. PMID: 6975138.
      View in: PubMed
    174. Hartmann DW, Entringer MA, Robinson WA, Vasil ML, Drebing CJ, Morton NJ, True L. Regulation of granulopoiesis and distribution of granulocytes in early phase of bacterial infection. J Cell Physiol. 1981 Oct; 109(1):17-24. PMID: 7035470.
      View in: PubMed
    175. Mangalik A, Robinson WA. Stem cell assays in the evaluation of myelotoxicity. Environ Health Perspect. 1981 Jun; 39:51-8. PMID: 7016522.
      View in: PubMed
    176. Hartmann DW, Robinson WA, Mangalik A, Glode LM, Triebel F. Unanticipated side effects from treatment with high-dose mechlorethamine in patients with malignant melanoma. Cancer Treat Rep. 1981 Mar-Apr; 65(3-4):327-8. PMID: 7237455.
      View in: PubMed
    177. Robinson WA, Hartmann DW, Mangalik A, Morton N, Joshi JH. Autologous nonfrozen bone marrow transplantation after intensive chemotherapy: a pilot study. Acta Haematol. 1981; 66(3):145-53. PMID: 6795872.
      View in: PubMed
    178. McCabe ER, Melvin TR, O'Brien D, Montgomery RR, Robinson WA, Bhasker C, Brown BI. Neutropenia in a patient with type IB glycogen storage disease: in vitro response to lithium chloride. J Pediatr. 1980 Dec; 97(6):944-6. PMID: 6255121.
      View in: PubMed
    179. Robinson WA, Entringer MA, Huber J, Gupta R. In vivo and in vitro effects of lithium on granulopoiesis in human neutropenic disorders. Adv Exp Med Biol. 1980; 127:281-91. PMID: 6967680.
      View in: PubMed
    180. Joshi JH, Entringer MA, Robinson WA. Bacterial stimulation of serum colony-stimulating activity and neutrophil production in germ-free mice. Proc Soc Exp Biol Med. 1979 Oct; 162(1):44-7. PMID: 388453.
      View in: PubMed
    181. Mahmood T, Robinson WA, Hamstra RD, Wallner SF. Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes: the 5q-syndrome, a distinct entity. Am J Med. 1979 Jun; 66(6):946-50. PMID: 453227.
      View in: PubMed
    182. Singer JW, Fialkow PJ, Steinmann L, Najfeld V, Stein SJ, Robinson WA. Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro. Blood. 1979 Feb; 53(2):264-8. PMID: 282920.
      View in: PubMed
    183. Mahmood T, Robinson WA, Entringer M. Autologous bone-marrow and peripheral blood buffy coat cell infusion in the treatment of chronic myeloid and acute leukemia. Exp Hematol. 1979; 7 Suppl 5:321-6. PMID: 400695.
      View in: PubMed
    184. Mangalik A, Robinson WA, Bolin R, Mangalik A, Entringer M. CFU-C and colony stimulating activity in human aplastic anemia. Haematol Blood Transfus. 1979; 24:87-95. PMID: 317262.
      View in: PubMed
    185. Mangalik A, Robinson WA, Morton NJ. Stem cell kinetics in humans: studies during autologous nonfrozen bone marrow transplantation. Exp Hematol. 1979; 7 Suppl 5:188-99. PMID: 400686.
      View in: PubMed
    186. Robinson WA, Drebing C, Mahmood T, Entringer M, Redecker S. Recovery of CFU-C after freezing of normal and leukemic human bone marrow. Exp Hematol. 1979; 7 Suppl 5:27-37. PMID: 400689.
      View in: PubMed
    187. Robinson WA. Current concepts of abnormal stem cell proliferation in human disease. Acta Haematol. 1979; 62(5-6):331-7. PMID: 121678.
      View in: PubMed
    188. Robinson WA. White blood cell interaction in granulocyte regulation. J Reticuloendothel Soc. 1978 Nov; 24(5):583-7. PMID: 366133.
      View in: PubMed
    189. Mahmood T, Robinson WA. Granulocyte modulation of endotoxin-stimulated colony-stimulating activity (CSA) production. Blood. 1978 May; 51(5):879-87. PMID: 638250.
      View in: PubMed
    190. Mahmood T, Robinson WA. Effect of levamisole on human granulopoiesis in vitro. Proc Soc Exp Biol Med. 1977 Nov; 156(2):359-64. PMID: 303776.
      View in: PubMed
    191. Mahmood T, Robinson WA, Kurnick JE, Vautrin R. Granulopoietic and erythropoietic activity in patients with anemias of iron deficiency and chronic disease. Blood. 1977 Sep; 50(3):449-55. PMID: 301761.
      View in: PubMed
    192. Mangalik A, Robinson WA, Holton CP. Granulopoietic studies in acute lymphocytic leukemia of children. Blut. 1977 Feb; 34(2):77-88. PMID: 300034.
      View in: PubMed
    193. Petersen CD, Robinson WA, Kurnick JE. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci. 1976 Sep-Oct; 272(2):161-5. PMID: 1008078.
      View in: PubMed
    194. Gupta RC, Robinson WA, Kurnick JE. Felty's syndrome. Effect of lithium on granulopoiesis. Am J Med. 1976 Jul; 61(1):29-32. PMID: 937368.
      View in: PubMed
    195. Robinson WA, Stonington OG. Leitartikel. Blut. 1976 Jan; 32(1):1-12. PMID: 764901.
      View in: PubMed
    196. Gupta R, Robinson WA, Albrecht D. Granulopoietic activity in Felty's syndrome. Ann Rheum Dis. 1975 Apr; 34(2):156-61. PMID: 49177.
      View in: PubMed
    197. Gupta RC, Robinson WA, Smyth CJ. Efficacy of lithium in rheumatoid arthritis with granulocytopenia (felty's syndrome). A preliminary report. Arthritis Rheum. 1975 Mar-Apr; 18(2):179-84. PMID: 1131284.
      View in: PubMed
    198. Gray JL, Robinson WA. Treatment of adult acute non-lymphocytic leukemia. Rocky Mt Med J. 1975 Jan; 72(1):13-6. PMID: 1111047.
      View in: PubMed
    199. Robinson WA, Mangalik A. The kinetics and regulation of granulopoiesis. Semin Hematol. 1975 Jan; 12(1):7-25. PMID: 1088999.
      View in: PubMed
    200. Ward HP, Vautrin R, Kurnick J, Robinson WA. Presence of a myeloproliferative factor in patients with polycythemia vera and agnogenic myeloid metaplasia. I. Expansion of the erythropoietin-responsive stem cell compartment. Proc Soc Exp Biol Med. 1974 Oct; 147(1):305-8. PMID: 4531056.
      View in: PubMed
    201. Gibson EL, Herbert V, Robinson WA. Granulocyte colony stimulating activity and vitamin B12 binding proteins in human urine. Br J Haematol. 1974 Oct; 28(2):191-7. PMID: 4530730.
      View in: PubMed
    202. Robinson WA. Granulocytosis in neoplasia. Ann N Y Acad Sci. 1974; 230:212-8. PMID: 4522870.
      View in: PubMed
    203. Mangalik A, Robinson WA. Cyclic neutropenia: the relationship between urine granulocyte colony stimulating activity and neutrophil count. Blood. 1973 Jan; 41(1):79-84. PMID: 4682083.
      View in: PubMed
    204. Mack T, Robinson WA, Holton CP. Colony growth of peripheral blood cells from patients with acute lymphocytic leukemia. Cancer Res. 1972 Oct; 32(10):2054-7. PMID: 4507648.
      View in: PubMed
    205. Kurnick JE, Robinson WA. Combination chemotherapy of advanced lymphomas. Arch Intern Med. 1972 Jun; 129(6):908-13. PMID: 5067727.
      View in: PubMed
    206. Atkins RC, Robinson WA, Trimble C, Eiseman B. In vitro challenge and antibody production of the ex vivo perfused spleen. J Surg Res. 1970 Aug; 10(8):353-6. PMID: 5428098.
      View in: PubMed
    207. Robinson WA, Pike BL. Leukopoietic activity in human urine. The granulocytic leukemias. N Engl J Med. 1970 Jun 04; 282(23):1291-7. PMID: 5266478.
      View in: PubMed
    208. Robinson WA, Stanley ER, Metcalf D. Stimulation of bone marrow colony growth in vitro by human urine. Blood. 1969 Mar; 33(3):396-9. PMID: 5766776.
      View in: PubMed
    Robinson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)